Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000206 · ClinicalTrials.gov registry record · Phase 2
Clinical Rescue Protocol - 2
A Phase 2 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00000206 is a Phase 2 study that has completed, run by University of California, Los Angeles.
The verdict
NCT00000206, a Phase 2 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to detect increasing medication dose results in heroin cessation for patients still using, to determine if decreasing medication dose in patients unable to tolerate medication dose increases retention, and to determine if blood levels of methadone or buprenorphine correlate with clinical response.
Interventions
- DRUG Buprenorphine
Trial Details
| Field | Value |
|---|---|
| Start Date | 1991-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000206
The ClinicalTrials.gov registry entry for NCT00000206 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Buprenorphine is the first listed.
NCT00000206 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000206 about?
NCT00000206 is a clinical study titled "Clinical Rescue Protocol - 2". The purpose of this study is to detect increasing medication dose results in heroin cessation for patients still using, to determine if decreasing medication dose in patients unable to tolerate medication dose increases retention, and to determine if blood levels of methadone or buprenorphine correl...
What is the current status of trial NCT00000206?
This trial is currently completed. It is a Phase 2 study. The study started on 1991-04.
What interventions are being tested in trial NCT00000206?
The interventions under investigation include: Buprenorphine (DRUG).
Who is sponsoring clinical trial NCT00000206?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.